Invest in better immunocontraception with pZP vaccine

Investment Thesis


  • Proof of concept complete with over eight studies demonstrating fertility control in wildlife field trials
  • Clear development pathway
  • EPA approval expected by 1Q 2020
  • Revenue can be generated quickly
  • Positive ROI and ROE 
  • Commercial-ready in one year from closing on funding means cashflow can fund life-cycle management and portfolio expansion to develop vaccines for other species without need for additional dilutive funding
  • For information on investing contact us

Opportunity / Unmet Need


  • Immunocontraception has immediate application in control of overabundant wild horse populations and urban deer. 
  • Feral Cats
  • Feral Dogs
  • Macaques
  • Wild Burros
  • Feral Cattle
  • Feral Camels
  • Feral Hogs

Use of Proceeds and Development Plan



  • Create, standardize and validate manufacturing protocol 
  • Compile submission dossier for EPA
  • QA:Manufacture batches to affirm antibody response and release specs
  • Field testing of SpayVac immunocontraception with potential customers
  • Vaccination of additional overabundant species to expand usage to a greater number of species
  • Develop other immunocontraceptive vaccines for feral cats and feral dogs
  • Set up long-term production facility

We are seeking investors

SpayVac for Wild seeks investors and partners

We are ambitious and would like to fund as much development as possible into pZP immunocontraception and other methods of immunocontraception.  Please contact us if you are interested in being part of this exciting opportunity.

To receive a non-confidential slide deck, email us

Contact Info

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

SpayVac for Wildlife Inc.

8617 Lochside Drive, North Saanich, BC V8L1M8, CA & 2661 Aberdeen Court, Madison, WI, 53711 USA

1 (877) 510-6812